Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO $39.15)
- $39.15 P/E (TTM): 11.2X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Eli Lilly and Company (LLY $921.48)
- $921.48 P/E (TTM): 40.08X Cap: $870.63B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $39.15)
- $39.15 P/E (TTM): 11.2X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Vanguard Health Care ETF (VHT $274.07)
- $274.07 P/E (TTM): 24.74X Cap: $17.32B
- View VHT Profile
- View Questions on VHT
iShares U.S. Healthcare ETF (IYH $61.70)
- $61.70 P/E (TTM): 24.16X Cap: $2.90B
- View IYH Profile
- View Questions on IYH

Q: I have a > 50% loss on NVO in an RSP, so I'm unable to harvest the tax loss. Do you feel I would break even faster if I, held, sold and bought a US dollar health ETF or LLY? I'm starting to think healthcare ETF, as if I pick the wrong horse, I can end up in the same situation again. What are your recommendations? Healthcare fits in best for my portfolio weightings.

Thanks

Read Answer Asked by Brad on April 09, 2026

Novo Nordisk A/S (NVO $39.15)
- $39.15 P/E (TTM): 11.2X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: A very unfortunate investment that I was hoping would turn a little before I dump it. Down 53%……is there any point in waiting for improvement.
Len

Read Answer Asked by Leonard on February 24, 2026

Eli Lilly and Company (LLY $921.48)
- $921.48 P/E (TTM): 40.08X Cap: $870.63B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $39.15)
- $39.15 P/E (TTM): 11.2X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Hims & Hers Health Inc. Class A (HIMS $29.01)
- $29.01 P/E (TTM): 62.02X Cap: $5.53B
- View HIMS Profile
- View Questions on HIMS

Q: Greetings,

Is the sell off in NOVO Nordisk warranted? Seems a bit harsh me thinks.

Just when the stock was pulling out of a tax loss selling nose dive, it now seems to have run out of gas and is falling again.

1) Should we view such a steep drop as possibly an over reaction? Should we wait to see if a bottom forms before stepping in? Buy, sell or hold?

2) I know 5i favours Eli Lilly but has most of the growth already taken place or do you predict even higher altitudes? Buy now or wait for a dip?

Cheers
A

Read Answer Asked by Arzoo on February 06, 2026